Our retina-first AI platform turns any smartphone into a powerful, precision diagnostic tool. With just a mobile camera, frontline providers can now detect early signs of diabetic retinopathy, instantly and accurately—without the need for bulky fundus cameras or specialist referrals.
Adults with diabetes worldwide
Will develop diabetic retinopathy
Preventable with early detection
Diabetic retinopathy is the leading cause of blindness in working-age adults. Yet millions remain undiagnosed due to limited access to specialists and infrastructure. Nexthria bridges this gap—bringing world-class diagnostics to rural clinics, pharmacies, mobile health units, and national screening programs across South and Southeast Asia.
Trusted by healthcare systems worldwide
Nexthria harnesses deep learning, on-device intelligence, and modular triage engines to deliver medical-grade retinal screening in seconds. Our system analyzes retinal images with explainable AI, flagging abnormalities before vision loss becomes irreversible.
Exceptional accuracy on referable diabetic retinopathy cases with medical-grade precision.
Instant analysis on mobile or edge devices without requiring cloud connectivity.
Multilingual UI designed for deployment in low-resource and underserved regions worldwide.
We collaborate with leading ophthalmologists, diabetic specialists, and R&D institutions to continuously validate our models across diverse populations. Our platform complies with global healthcare standards, ensuring patient privacy, clinical-grade accuracy, and ethical AI development.
End-to-end encryption and secure data handling that meets healthcare privacy standards.
Advanced deep learning algorithms with intelligent triage and modular architecture for scalable healthcare solutions.
Peer-reviewed studies across diverse populations validate our AI model performance.
Incubator & Partners



Join us in revolutionizing retinal diagnostics and preventing preventable blindness worldwide.